On February 5, 2025, in connection with the IPO, James Murren, Joyce Arpin and Geoff Freeman (collectively with Edward King and Daniel Fetters, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On February 5, 2025, in connection with the IPO, James Murren, Joyce Arpin and Geoff Freeman (collectively with Edward King and Daniel Fetters, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On February 5, 2025, in connection with the IPO, James Murren, Joyce Arpin and Geoff Freeman (collectively with Edward King and Daniel Fetters, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Joyce Arpin was appointed as Director at K&F GROWTH ACQUISITION CORP. II.
Action
appointed
Role
Director
Exact text from the filing
On February 5, 2025, in connection with the IPO, James Murren, Joyce Arpin and Geoff Freeman (collectively with Edward King and Daniel Fetters, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Geoff Freeman was appointed as Director at K&F GROWTH ACQUISITION CORP. II.
Action
appointed
Role
Director
Exact text from the filing
On February 5, 2025, in connection with the IPO, James Murren, Joyce Arpin and Geoff Freeman (collectively with Edward King and Daniel Fetters, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
James Murren was appointed as Director at K&F GROWTH ACQUISITION CORP. II.
Action
appointed
Role
Director
Exact text from the filing
On February 5, 2025, in connection with the IPO, James Murren, Joyce Arpin and Geoff Freeman (collectively with Edward King and Daniel Fetters, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.